GR3035379T3 - Tetrazolyl-substituted quinuclidines as substance P antagonists - Google Patents
Tetrazolyl-substituted quinuclidines as substance P antagonistsInfo
- Publication number
- GR3035379T3 GR3035379T3 GR20010400206T GR20010400206T GR3035379T3 GR 3035379 T3 GR3035379 T3 GR 3035379T3 GR 20010400206 T GR20010400206 T GR 20010400206T GR 20010400206 T GR20010400206 T GR 20010400206T GR 3035379 T3 GR3035379 T3 GR 3035379T3
- Authority
- GR
- Greece
- Prior art keywords
- alkyl
- halo
- disorders
- hydrogen
- analgesics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB9600934 | 1996-09-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3035379T3 true GR3035379T3 (en) | 2001-05-31 |
Family
ID=11004477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20010400206T GR3035379T3 (en) | 1996-09-12 | 2001-02-07 | Tetrazolyl-substituted quinuclidines as substance P antagonists |
Country Status (10)
Country | Link |
---|---|
US (1) | US5939434A (da) |
EP (1) | EP0829480B1 (da) |
JP (1) | JP3273750B2 (da) |
AT (1) | ATE198201T1 (da) |
CA (1) | CA2215020C (da) |
DE (1) | DE69703725T2 (da) |
DK (1) | DK0829480T3 (da) |
ES (1) | ES2152633T3 (da) |
GR (1) | GR3035379T3 (da) |
MX (1) | MX9706944A (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6953855B2 (en) * | 1998-12-11 | 2005-10-11 | Targacept, Inc. | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
US20040142929A1 (en) * | 2001-07-06 | 2004-07-22 | Ramon Merce-Vidal | Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence |
US6861526B2 (en) | 2002-10-16 | 2005-03-01 | Pfizer Inc. | Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine |
WO2005012267A1 (ja) | 2003-08-01 | 2005-02-10 | Toyo Kasei Kogyo Company Limited | アルコキシ-テトラゾール-1-イル-ベンズアルデヒド化合物およびその製造方法 |
WO2005043153A1 (en) * | 2003-10-27 | 2005-05-12 | Meyer Donald W | Transmissible spongiform encephalopathy detection in cervids, sheep and goats |
JP5172124B2 (ja) | 2006-09-29 | 2013-03-27 | 関東化学株式会社 | 2位に置換基を有する光学活性キヌクリジノール類の製造方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4680283A (en) * | 1984-09-26 | 1987-07-14 | Merck & Co., Inc. | Analogs of substance P and eledoisin |
WO1990005525A1 (en) * | 1988-11-23 | 1990-05-31 | Pfizer Inc. | Quinuclidine derivatives as substance p antagonists |
ATE154354T1 (de) * | 1991-02-11 | 1997-06-15 | Merck Sharp & Dohme | Azabicyclische verbindungen, diese enthaltende pharmazeutische zubereitungen und ihre therapeutische verwendung |
US5716965A (en) * | 1991-05-22 | 1998-02-10 | Pfizer Inc. | Substituted 3-aminoquinuclidines |
DE9290057U1 (de) * | 1991-05-22 | 1994-01-05 | Pfizer | Substituierte 3-Aminochinuclidine |
US5288730A (en) * | 1991-06-24 | 1994-02-22 | Merck Sharp & Dohme Limited | Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy |
ES2149767T5 (es) * | 1991-09-20 | 2005-06-16 | Glaxo Group Limited | Nuevo uso medico para antagonistas de taquiquininas. |
US5569662A (en) * | 1992-03-23 | 1996-10-29 | Pfizer Inc. | Quinuclidine derivatives as substance P antagonists |
JP2656702B2 (ja) * | 1992-03-23 | 1997-09-24 | ファイザー製薬株式会社 | ペプチド性キヌクリジン |
US5604241A (en) * | 1992-10-21 | 1997-02-18 | Pfizer Inc. | Substituted benzylaminoquinuclidines as substance P antagonists |
JP2656700B2 (ja) * | 1992-10-28 | 1997-09-24 | ファイザー製薬株式会社 | 置換キヌクリジン誘導体 |
IL109646A0 (en) * | 1993-05-19 | 1994-08-26 | Pfizer | Heteroatom substituted alkyl benzylamino-quinuclidines |
DK0708771T3 (da) * | 1993-07-15 | 1999-06-21 | Pfizer | Benzyloxyquinuclidiner som substans P antagonister |
IL111002A (en) * | 1993-09-22 | 1998-09-24 | Glaxo Group Ltd | History of piperidine, their preparation and the pharmaceutical preparations containing them |
-
1996
- 1996-09-12 MX MX9706944A patent/MX9706944A/es active IP Right Grant
-
1997
- 1997-08-28 DE DE69703725T patent/DE69703725T2/de not_active Expired - Fee Related
- 1997-08-28 EP EP97306612A patent/EP0829480B1/en not_active Expired - Lifetime
- 1997-08-28 ES ES97306612T patent/ES2152633T3/es not_active Expired - Lifetime
- 1997-08-28 AT AT97306612T patent/ATE198201T1/de not_active IP Right Cessation
- 1997-08-28 DK DK97306612T patent/DK0829480T3/da active
- 1997-09-05 US US08/924,171 patent/US5939434A/en not_active Expired - Fee Related
- 1997-09-10 CA CA002215020A patent/CA2215020C/en not_active Expired - Fee Related
- 1997-09-11 JP JP26296597A patent/JP3273750B2/ja not_active Expired - Fee Related
-
2001
- 2001-02-07 GR GR20010400206T patent/GR3035379T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5939434A (en) | 1999-08-17 |
MX9706944A (es) | 1998-08-30 |
EP0829480B1 (en) | 2000-12-20 |
DK0829480T3 (da) | 2001-02-19 |
ATE198201T1 (de) | 2001-01-15 |
DE69703725D1 (de) | 2001-01-25 |
EP0829480A2 (en) | 1998-03-18 |
DE69703725T2 (de) | 2001-04-26 |
CA2215020C (en) | 2000-05-16 |
CA2215020A1 (en) | 1998-03-12 |
JPH1087661A (ja) | 1998-04-07 |
JP3273750B2 (ja) | 2002-04-15 |
ES2152633T3 (es) | 2001-02-01 |
EP0829480A3 (en) | 1998-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2226292A1 (en) | Substituted benzolactam compounds as substance p antagonists | |
PT1029853E (pt) | Derivados biciclicos heteroaromaticos uteis como agentes anticancerigenos | |
BR0002936A (pt) | Compostos de biciclicarbonil-indol como agentes antiinflamatórios/analgésicos | |
CA2310627A1 (en) | Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists | |
ES2184960T3 (es) | Nuevas pirimidin-4-onas-(5,6)-heteroaril condensadas 2,3 disustituidas. | |
ATE211729T1 (de) | Therapeutisch wirksame verbindungen | |
PT984019E (pt) | Carbamatos antibacterianos em c11 de macrolidos | |
GR3035379T3 (en) | Tetrazolyl-substituted quinuclidines as substance P antagonists | |
HU9400908D0 (en) | Pharmaceutical compositions for treatng skin disorders | |
ES2180693T3 (es) | 3-((bencil 5-sustituido)amino)-2-fenilpiperidinas como antagonistas de la sustancia p. | |
HK1019710A1 (en) | Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient | |
PT1049672E (pt) | Derivados de azetidinocarboxamida para o tratamento de disturbios do snc | |
DE69203194D1 (de) | Thiazolidine-2,4-dione für die Behandlung der Hypertonie. | |
TW275629B (da) | ||
PT1049670E (pt) | Derivados de azetidinocarboxamida para o tratamento de perturbacoes do snc | |
ES2150739T3 (es) | Compuestos triciclicos de piperidinilamino como antagonistas de sustancia p. | |
ES2116528T3 (es) | Nuevo compuesto, la leustroducsina h, su preparacion y su utilizacion terapeutica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ML | Lapse due to non-payment of fees |